150 related articles for article (PubMed ID: 33468073)
21. ESBL colonization and acquisition in a hospital population: The molecular epidemiology and transmission of resistance genes.
Hagel S; Makarewicz O; Hartung A; Weiß D; Stein C; Brandt C; Schumacher U; Ehricht R; Patchev V; Pletz MW
PLoS One; 2019; 14(1):e0208505. PubMed ID: 30640915
[TBL] [Abstract][Full Text] [Related]
22. Surgical site infection with extended-spectrum β-lactamase-producing Enterobacteriaceae after cardiac surgery: incidence and risk factors.
Jolivet S; Lescure FX; Armand-Lefevre L; Raffoul R; Dilly MP; Ghodbane W; Nataf P; Lucet JC
Clin Microbiol Infect; 2018 Mar; 24(3):283-288. PubMed ID: 28698036
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.
Zeynudin A; Pritsch M; Schubert S; Messerer M; Liegl G; Hoelscher M; Belachew T; Wieser A
BMC Infect Dis; 2018 Oct; 18(1):524. PubMed ID: 30342476
[TBL] [Abstract][Full Text] [Related]
24. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.
Ludden C; Cormican M; Vellinga A; Johnson JR; Austin B; Morris D
BMC Infect Dis; 2015 Apr; 15():168. PubMed ID: 25887288
[TBL] [Abstract][Full Text] [Related]
25. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
[TBL] [Abstract][Full Text] [Related]
26. Occurrence and characteristics of extended spectrum beta-lactamases-producing Enterobacteriaceae from foods of animal origin.
Tekiner İH; Özpınar H
Braz J Microbiol; 2016; 47(2):444-51. PubMed ID: 26991276
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.
Eltai NO; Al Thani AA; Al-Ansari K; Deshmukh AS; Wehedy E; Al-Hadidi SH; Yassine HM
Antimicrob Resist Infect Control; 2018; 7():90. PubMed ID: 30069306
[TBL] [Abstract][Full Text] [Related]
28. Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community.
van Hoek AH; Schouls L; van Santen MG; Florijn A; de Greeff SC; van Duijkeren E
PLoS One; 2015; 10(6):e0129085. PubMed ID: 26029910
[TBL] [Abstract][Full Text] [Related]
29. Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) colonization as a risk factor for developing ESBL infections in pediatric cardiac surgery patients: "retrospective cohort study".
Cheikh A; Belefquih B; Chajai Y; Cheikhaoui Y; El Hassani A; Benouda A
BMC Infect Dis; 2017 Mar; 17(1):237. PubMed ID: 28356079
[TBL] [Abstract][Full Text] [Related]
30. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and Genotypic Characterization of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Asymptomatic Bacteriuria in Pregnancy.
Youssef MM; Rizk HA; Hassuna NA
Microb Drug Resist; 2019 Jun; 25(5):731-738. PubMed ID: 30676863
[TBL] [Abstract][Full Text] [Related]
32. Extended-spectrum β-lactamase- and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area.
Wielders CCH; van Hoek AHAM; Hengeveld PD; Veenman C; Dierikx CM; Zomer TP; Smit LAM; van der Hoek W; Heederik DJ; de Greeff SC; Maassen CBM; van Duijkeren E
Clin Microbiol Infect; 2017 Feb; 23(2):120.e1-120.e8. PubMed ID: 27773759
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (ESBL) Producing Enterobacteriaceae Isolated from Three Centers of Tehran, Iran.
Ghanavati R; Ohadi E; Kazemian H; Yazdani F; Torki A; Kalani BS; Irajian G
Recent Pat Antiinfect Drug Discov; 2018; 13(2):180-186. PubMed ID: 29769010
[TBL] [Abstract][Full Text] [Related]
34. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
[TBL] [Abstract][Full Text] [Related]
35. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
[TBL] [Abstract][Full Text] [Related]
37. Neonatal intestinal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae-a 5-year follow-up study.
Nordberg V; Jonsson K; Giske CG; Iversen A; Aspevall O; Jonsson B; Camporeale A; Norman M; Navér L
Clin Microbiol Infect; 2018 Sep; 24(9):1004-1009. PubMed ID: 29326011
[TBL] [Abstract][Full Text] [Related]
38. Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.
Uemura M; Imataki O; Uchida S; Nakayama-Imaohji H; Ohue Y; Matsuka H; Mori H; Dobashi H; Kuwahara T; Kadowaki N
BMC Infect Dis; 2017 Jan; 17(1):26. PubMed ID: 28056827
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of extended-spectrum beta-lactamases producing Enterobacteriaceae colonization among patients abdominal surgery patients.
Apisarnthanarak A; Kondo S; Mingmalairak C; Mahawongkajit P; Juntong J; Limpavitayaporn P; Sriussadaporn E; Tongyoo A; Mundy LM
Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1290-1293. PubMed ID: 31481134
[TBL] [Abstract][Full Text] [Related]
40. High Prevalence of CTX-M Beta-Lactamases in Enterobacteriaceae from Healthy Individuals in Guangzhou, China.
Zhou Y; Wu X; Zhang J; Tao X; Deng Z; Hu Y; Li M; Yang X; Wang M; Yang Z
Microb Drug Resist; 2015 Aug; 21(4):398-403. PubMed ID: 25756950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
